Skip to content

Risk assessment and prognostic value of high-frequency QRS for adverse cardiac events after PCI

Risk assessment and prognostic value of high-frequency QRS for adverse cardiac events after PCI

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104931
Enrollment
Unknown
Registered
2025-06-25
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease

Interventions

Resting HFQRS showed a positive group of postoperative myocardial ischemia:None
Resting HFQRS showed that the postoperative myocardial ischemia negative group:None

Sponsors

Chengdu Third People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.All patients who were evaluated by clinicians and were scheduled to undergo PCI surgery 2. Aged 18 to 80 years old; 3. Be able to understand the purpose of the study, voluntarily participate in this study, have the patient themselves or their legal representatives sign the informed consent form, and be willing to complete the follow-up as required by the protocol.

Exclusion criteria

Exclusion criteria: 1. QRS>130ms or placement pacemaker patients 2. Stroke within 30 days before surgery; 3. STEMI, cardiopulmonary resuscitation or cardiogenic shock within 48 hours before surgery; 4. Plan to undergo other cardiac surgery (such as aortic valve replacement, coronary artery bypass grafting, etc.) within 30 days after surgery; 5. Severe hepatic and renal insufficiency or bleeding tendency; 6. Known allergy to contrast media; 7. Severe narrowing or occlusion of blood vessels at the proposed puncture site or uncontrollable skin infection; 8. Females of childbearing age who are pregnant or lactating; 9. Other subjects who have other contraindications for interventional treatment, and other subjects who are judged by the investigator to be unsuitable for participating in this study.

Design outcomes

Primary

MeasureTime frame
Cardiogenic death;Acute myocardial infarction;Stroke;Recurrent angina pectoris;Heart failure;

Secondary

MeasureTime frame
Target lesion revascularizition;Coronary restenosis;Malignant arrhythmia;

Countries

China

Contacts

Public ContactZhen Zhang

Chengdu Third People's Hospital

zhangzhen@swjtu.edu.cn+86 137 0804 2927

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026